3D printed models co-sponsored clinical study by Ricoh USA and Stratasys Ltd. for orthopedic tumor removal assessment.

Ricoh USA and Stratasys Ltd. co-sponsor a landmark clinical study, enrolling the first patient for assessment of 3D printed models' efficacy in orthopedic tumor removal. The study aims to compare patient-specific 3D models to traditional CT/MRI imaging for preoperative planning and tumor excision, potentially improving surgical outcomes such as blood loss, operating time, and procedural risks.